MYNZ
Mainz Biomed B.V.
Mainz Biomed B.V. (MYNZ) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 45.3, with 3/3 trend checks passing.
MYNZ with MA50 and MA200
Key levels & signals
Mainz Biomed B.V. (MYNZ) is still trading in a constructive trend overall. The latest available price is $3.59, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 16.7% and above the 200-day moving average by 37.2%.
MYNZ currently has an RSI reading of 45.3, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
For traders reviewing MYNZ next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About Mainz Biomed B.V.
Mainz Biomed B.V. is a German company specializing in molecular genetics for the development of cancer diagnostics. The firm engineers both in-vitro diagnostic (IVD) tools and assays designed exclusively for research, primarily catering to clinical applications within human genetics. Among its key offerings is ColoAlert, a screening test for detecting colorectal cancer. Additionally, they are developing PancAlert, a promising product candidate intended for pancreatic cancer screening. Beyond cancer, Mainz Biomed also provides GenoStrip, a molecular genetic solution for identifying pathogens in various environments. Established in 2008, the company maintains its headquarters in Mainz, Germany.
Learn the indicators behind this page
More stock opportunities
Common questions about MYNZ
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.